Mirabella Financial Services’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-14,895
Closed -$323K – 1134
2025
Q4
$323K Buy
+14,895
New +$294K 0.03% 429
2023
Q4
– Sell
-34,583
Closed -$404K – 564
2023
Q3
$404K Buy
34,583
+1,362
+4% +$15.4K 0.06% 247
2023
Q2
$335K Sell
33,221
-123,851
-79% -$1.11M 0.04% 347
2023
Q1
$1.16M Buy
+157,072
New +$1.29M 0.18% 115

Other funds holding ROIV

Mirabella Financial Services's ROIV Position: Q1 2026 in Review

Mirabella Financial Services sold out of Roivant Sciences (ROIV) in Q1 2026, closing a stake of 14,895 shares — an estimated $323K sold.

Mirabella Financial Services first reported a position in ROIV in Q1 2023 and held it in 4 quarters. The position peaked at $1.16M in Q1 2023. 445 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

  • Mirabella Financial Services reported no remaining Roivant Sciences position as of Q1 2026 after selling out during the quarter.
  • Mirabella Financial Services sold 14,895 Roivant Sciences shares in Q1 2026, an estimated $323K.
  • Mirabella Financial Services first reported a position in Roivant Sciences in Q1 2023 and held it in 4 quarters.
  • Mirabella Financial Services's Roivant Sciences position peaked at $1.16M in Q1 2023.
  • 445 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on Mirabella Financial Services's 13F filing for Q1 2026, filed 12 May 2026.